Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
Eclinicalmedicine
|
January 26, 2024
15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis
Mahati Paravathaneni, Houssein Safa, Vidhu Joshi, et al.
Cancer Medicine
|
September 28, 2020
Influence of gene expression on survival of clear cell renal cell carcinoma
Anders Berglund, Ernest K Amankwah, Young-Chul Kim, et al.
JCO Clinical Cancer Informatics
|
July 26, 2024
Feasibility of a Smartphone Application for Education and Symptom Management of Patients With Renal Cell Carcinoma on Combined Tyrosine Kinase and Immune Checkpoint Inhibitors
Gabriel Roman Souza, Kea Turner, Keerthi Gullapalli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2026
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A Srour, Jad Chahoud, Alexandra Drakaki, et al.
Molecular Cancer Therapeutics
|
June 24, 2025
PV-10 triggers immunogenic cell death in head and neck squamous cell carcinoma via endoplasmic reticulum stress and apoptosis
Sowjanya Thatikonda, Ritu Chaudhary, Yeva Meshkovska, et al.
Nature Communications
|
May 3, 2020
Effective combinatorial immunotherapy for penile squamous cell carcinoma
Tianhe Huang, Xi Cheng, Jad Chahoud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2018
Updated Results of Rituximab Pre- and Post-BEAM with or without <sup>90</sup>Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma
Jad Chahoud, Dawen Sui, William D Erwin, et al.
Plos One
|
April 21, 2021
Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma
Nicholas H Chakiryan, Gregory J Kimmel, Youngchul Kim, et al.
The Journal of Urology
|
May 25, 2021
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies
Nicholas H Chakiryan, Aaron Dahmen, Marco Bandini, et al.
Urologic Oncology
|
November 14, 2020
Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors
Jad Chahoud, Pavlos Msaouel, Jeremy A Ross, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
Eclinicalmedicine
|
January 26, 2024
15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis
Mahati Paravathaneni, Houssein Safa, Vidhu Joshi, et al.
Cancer Medicine
|
September 28, 2020
Influence of gene expression on survival of clear cell renal cell carcinoma
Anders Berglund, Ernest K Amankwah, Young-Chul Kim, et al.
JCO Clinical Cancer Informatics
|
July 26, 2024
Feasibility of a Smartphone Application for Education and Symptom Management of Patients With Renal Cell Carcinoma on Combined Tyrosine Kinase and Immune Checkpoint Inhibitors
Gabriel Roman Souza, Kea Turner, Keerthi Gullapalli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2026
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A Srour, Jad Chahoud, Alexandra Drakaki, et al.
Molecular Cancer Therapeutics
|
June 24, 2025
PV-10 triggers immunogenic cell death in head and neck squamous cell carcinoma via endoplasmic reticulum stress and apoptosis
Sowjanya Thatikonda, Ritu Chaudhary, Yeva Meshkovska, et al.
Nature Communications
|
May 3, 2020
Effective combinatorial immunotherapy for penile squamous cell carcinoma
Tianhe Huang, Xi Cheng, Jad Chahoud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2018
Updated Results of Rituximab Pre- and Post-BEAM with or without <sup>90</sup>Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma
Jad Chahoud, Dawen Sui, William D Erwin, et al.
Plos One
|
April 21, 2021
Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma
Nicholas H Chakiryan, Gregory J Kimmel, Youngchul Kim, et al.
The Journal of Urology
|
May 25, 2021
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies
Nicholas H Chakiryan, Aaron Dahmen, Marco Bandini, et al.
Urologic Oncology
|
November 14, 2020
Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors
Jad Chahoud, Pavlos Msaouel, Jeremy A Ross, et al.
Page
of 10